
    
      This was a Phase IIb, randomized, double-blind, placebo-controlled, dose ranging, multicenter
      Study to determine the safety, tolerance, and efficacy of larazotide acetate in subjects with
      celiac disease during a gluten challenge. Subjects remained on their gluten-free diet
      throughout the duration of the trial. Study drug or drug placebo capsules were administered
      TID 15 minutes before each meal. Gluten or gluten placebo capsules will be taken TID with
      each meal.
    
  